HomeNewsTrendsHealthCOVID-19 infectiousness lasts more than 5 days, UK study finds

COVID-19 infectiousness lasts more than 5 days, UK study finds

The findings suggest that in people who develop symptoms, the majority are not infectious before symptoms develop, but two-thirds of cases are still infectious five days after their symptoms begin, notes the study, published in the Lancet Respiratory Medicine journal.

August 19, 2022 / 22:37 IST
Representative image

Most people with even mild COVID-19 are still infectious five days after symptoms begin, a new real-world study authored by an Indian-origin scientist in the UK has found.

Research by Imperial College London reported on Thursday that two-thirds of study participants were still infectious at five days and a quarter were still infectious at seven days. Professor Ajit Lalvani, Director of the NIHR Respiratory Infections Health Protection Research Unit at Imperial College London, said that combining the latest results with what is already known about the dynamics of Omicron infections the duration of infectiousness is broadly generalisable to all current COVID variants.

The findings suggest that in people who develop symptoms, the majority are not infectious before symptoms develop, but two-thirds of cases are still infectious five days after their symptoms begin, notes the study, published in the Lancet Respiratory Medicine journal.

The research also suggests that while lateral flow tests (LFTs) do not detect the start of infectiousness well, they more accurately identify when someone is no longer infectious and can safely leave isolation. We closely monitored people in their homes from when they were first exposed to the virus, capturing the moment when they developed infection through until they ceased being infectious, said Professor Lalvani, Director of the NIHR Respiratory Infections Health Protection Research Unit at Imperial College London.

Before this study we were missing half of the picture about infectiousness, because it's hard to know when people are first exposed to SARS-CoV-2 [COVID-19] and when they first become infectious. By using special daily tests to measure infectious virus (not just PCR) and daily symptom records we were able to define the window in which people are infectious. This is fundamental to controlling any pandemic and has not been previously defined for any respiratory infection in the community, he said. Our evidence can be used to inform infection control policies and self-isolation guidance to help reduce the transmission of SARS-CoV-2, he added.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

In the UK, the National Health Service (NHS) advice is for those with COVID symptoms to voluntarily self-isolate for five days to avoid spreading the disease. There is no longer a legal requirement to self-isolate if you test positive for COVID-19, but most people still want to isolate until they are not infectious. Despite this, there is lack of clarity around how to come out of self-isolation safely, said study co-author Dr Seran Hakki, from Imperial's National Heart and Lung Institute.

Our study is the first to assess how long infectiousness lasts for, using real-life evidence from naturally acquired infection. Our findings can thus inform guidance as to how to safely end self-isolation. If you test positive for COVID-19 or have symptoms after being in contact with someone with confirmed COVID-19, you should try to stay at home and minimise contact with other people, said Hakki. The study, covering 57 people with mild COVID, involved detailed daily tests from when people were exposed to SARS-CoV-2 the virus that causes COVID-19 to look at how much infectious virus they were shedding throughout their infection.

Its findings come as the latest official data on Friday showed that the number of people infected with coronavirus in the UK is continuing to fall. The Office for National Statistics (ONS) estimates 1.7 million people about one in 40 would have tested positive two weeks ago, which is down from 3.5 million in early July. The number of people dying of COVID-19 or being admitted to hospital with the virus is also falling.

PTI
first published: Aug 19, 2022 10:37 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347